The virus, believed, had finished talking to him. In a way, yes but this time it’s the vaccine that is scary!

We have lowered the curtain a little too soon: official pandemic was declared clinically dead on August 10. But we play extra time!


Early fears about the vaccine back to November 2009. We spoke at the time of possible contamination: a young woman recently vaccinated, it was learned, was diagnosed with Guillain-Barre syndrome, a rare neurological disease. And as always, we panic before thinking. In England, one third of nurses NHS (National Health Service), citing concerns about the relationship of the vaccine with Guillain-Barre Syndrome and neurological disorders, refused to be vaccinated against H1N1. The affair made a great noise, and then the other a hunting info. So case closed without further action until now.

Why such an investigation?

Of health professionals have given some disturbing reports of symptoms consistent with narcolepsy reported in adolescents aged 12 to 16 years, 1 to 2 months after vaccination against influenza A. But we remain in the field of investigation because at today’s date, despite several months of investigation, the Swedish Agency states that there is still no information sufficient to infer a link between Vaccination against influenza A by Pandemrix and reactions observed in these adolescents.


The problem, in fact, is that researchers lack information to the extent that the vaccine Pandemrix is recent. It was marketed in 2006 by Glaxo SmithKline. One can only hope that these concerns will prove unfounded as they are not less than 30 million Europeans who received the vaccine Pandemrix, including 4 million in the Hexagon, according to figures released by the French Agency health health products.

What is narcolepsy?

This is a neurological disorder that results in daytime sleepiness and muscle weakness.

Is this a serious illness?

The main symptom of narcolepsy or Gelineau disease is the presence of daily episodes of uncontrollable sleep. It can change in three quarters of cases, cataplexy. In both cases (narcolepsy and cataplexy), it is mainly the sleep is disturbed. For those who can distinguish, note that the patient with the disease either goes directly from wakefulness to REM sleep without intermediate steps. Other secondary symptoms may occur as hypnopompic or hypnagogic hallucinations, sleep paralysis, automatic acts.

How to tell if it is reached?

In France, the disease affects men more readily than women, and especially in adolescence and quarantine. Very few cases are identified (between 20 and 50 per 100 000). A figure probably far below the reality as it is estimated that only 20% of patients are aware of. To know for sure, one must have recourse to electroencephalography. Remains to be seen if the number of cases has increased in recent months after the wave of vaccination against influenza A. If Roselyne Bachelot falls asleep in public, it will have an excuse!